Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-25 @ 12:59 AM
NCT ID:
NCT02438293
Eligibility Criteria:
Inclusion Criteria:
* Children (\<12 year) with a congenital heart disease undergoing elective cardiac surgery
* Written informed consent by parents or guardian
Exclusion Criteria:
* No informed consent from one of the parents (or the legal representative if applicable)
* Anaesthesiologist or cardiopulmonary surgeon postpones surgery based on routine hospital screening
* Emergency surgery
* Pre-operative admission to the neonatology department
* Children not admitted to the intensive care unit after cardiac surgery
* Children undergoing a second cardiac operation during the same intensive care stay
* Children with duct-dependent physiology who remain prostaglandin-dependent after the heart operation (they will be excluded because they will certainly have a prolonged PICU LOS regardless of a possible rhinovirus infection). For example: hypoplastic left heart syndrome following pulmonary artery banding who will remain on prostaglandins until the next staged operation
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
12 Years
Study:
NCT02438293
Study Brief:
Protocol Section:
NCT02438293